Acerus Pharmaceuticals Corporation announced the acceptance of a scientific abstract reporting the results of the NATESTO® Spermatogenesis Study by the Endocrine Society for presentation at their Annual Meeting. Thomas Masterson, MD, Urology Fellow in the Department of Urology at the University of Miami School of Medicine, will present the NATESTO® clinical study results during a poster session at ENDO 2020, which will be held in San Francisco, CAMarch 28-31, 2020. The NATESTO® Spermatogenesis Study has been conducted under the direction of principal investigator Ranjith Ramasamy, MD, Associate Professor and Director of Reproductive Urology, Department of Urology, University of Miami School of Medicine.